Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
4SC
company
About
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- €17.10M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Active
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€17.10M
4SC has raised a total of
€17.10M
in funding over 2 rounds. Their latest funding was raised on
Dec 12, 2000 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 12, 2000 | Series B | €17.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
4SC is funded by 1 investors.
Bayern Kapital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Bayern Kapital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
